Sage Therapeutics to Present Brexanolone Postpartum Depression Data and SAGE-217 Major Depressive Disorder ... - Business Wire (press release)

Submitted by Anonymous (not verified) on Tue, 04/17/2018 - 20:01

Sage Therapeutics to Present Brexanolone Postpartum Depression Data and SAGE-217 Major Depressive Disorder ...Business Wire (press release)American Psychiatric Association (APA) 2018 Annual Meeting, May 5-9, 2018 in New York. Date and Time: May 7, 2018, 10:00 a.m. – 12:00 p.m. ET; Location: Exhibit Halls 3A/3B, Level 3; Title: Efficacy and Safety of Brexanolone iv in Hummingbird 202B: A ...